Source: CropLife America



CropLife America expressed support for recommendations by the Office of Management and Budget (OMB) as part of its approval of the Environmental Protection Agency's new Information Collection Request (ICR) regarding Tier I screening for EPA's Endocrine Disruptor Screening Program. In its response, OMB advised EPA to accept Other Scientifically Relevant Information in performing Tier I assays "to the greatest extent possible."



"We're pleased OMB recognizes the relevance of the vast amount of data previously collected under the Federal Insecticide, Fungicide and Rodenticide Act (FIFRA) and readily available with regard to test orders," said Jay Vroom, CLA president and CEO. "Referencing these data on reproductive and developmental toxicity allows EPA to meet the program's requirements and minimizes unnecessary financial, time, and resource burdens on both the agency and industry."



CLA has advocated allowing the existing data to be used to address the requirements of the EDSP Tier 1. This would fulfill the EPA mandate under the Food Quality Protection Act to "minimize duplicative testing." Additionally, OMB advised that EPA must have a plan for evaluating Tier 1 data using standardized tools as part of a weight-of-evidence analysis prior to requesting any future ICR for additional chemicals. The current ICR is only good for the first 67 chemicals on the present screening list and expires in 36 months. Under the program, the agency must categorize all Tier I test order responses and present them in a summary report prior to October 2012.



"We look forward to continuing an active role in the development and implementation of EPA's endocrine screening science and policy process." CEO Vroom concluded. "CLA is gratified that OMB recognized issues with the program and has acted to ensure a more responsive approach to the initiative overall."